Aposcience AG: Clinical Trials

1 trial sponsored by Aposcience AG, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1

Follow Aposcience AG: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate Safety and Efficacy of APO-2 at Three Different Doses in Patients With Diabetic Foot Ulcer
APO-2, Placebo - Diabetic Foot Ulcer (DFU)
Phase 1 / Phase 2CompletedAposcience AG1592020-10-092024-01-31

Conditions studied

Diabetic Foot (1)

Countries

Austria (1)  ·  Czechia (1)  ·  Germany (1)  ·  Poland (1)

Top investigators

Hendrik J Ankersmit, Univ.Prof.Dr. (1)

Results publications

PMID 33407796